Trials / Completed
CompletedNCT01318252
AL-54478 Proof of Concept Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-54478 0.005% | |
| DRUG | Latanoprost 0.005% | |
| DRUG | AL-54478 Vehicle | Inactive ingredients used as a placebo comparator |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-03-18
- Last updated
- 2014-07-31
Source: ClinicalTrials.gov record NCT01318252. Inclusion in this directory is not an endorsement.